Human Health Holdings Yönetim

Yönetim kriter kontrolleri 3/4

Human Health Holdings CEO'su Kin Ping Chan, Jun2015 tarihinde atandı, in görev süresi 9.42 yıldır. in toplam yıllık tazminatı HK$ 4.36M olup, şirket hissesi ve opsiyonları dahil olmak üzere 57.5% maaş ve 42.5% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.8% ine doğrudan sahiptir ve bu hisseler HK$ 5.34M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 9.3 yıl ve 9.4 yıldır.

Anahtar bilgiler

Kin Ping Chan

İcra Kurulu Başkanı

HK$4.4m

Toplam tazminat

CEO maaş yüzdesi	57.5%
CEO görev süresi	9.4yrs
CEO sahipliği	1.8%
Yönetim ortalama görev süresi	9.3yrs
Yönetim Kurulu ortalama görev süresi	9.4yrs

Son yönetim güncellemeleri

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 25

Recent updates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 25

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

CEO Tazminat Analizi

Kin Ping Chan'un ücretlendirmesi Human Health Holdings'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	HK$4m	HK$3m	HK$24m
Mar 31 2024	n/a	n/a	-HK$22m
Dec 31 2023	n/a	n/a	-HK$67m
Sep 30 2023	n/a	n/a	HK$57m
Jun 30 2023	HK$5m	HK$2m	HK$181m
Mar 31 2023	n/a	n/a	HK$367m
Dec 31 2022	n/a	n/a	HK$553m
Sep 30 2022	n/a	n/a	HK$464m
Jun 30 2022	HK$3m	HK$2m	HK$375m
Mar 31 2022	n/a	n/a	HK$297m
Dec 31 2021	n/a	n/a	HK$218m
Sep 30 2021	n/a	n/a	HK$181m
Jun 30 2021	HK$2m	HK$2m	HK$144m
Mar 31 2021	n/a	n/a	HK$59m
Dec 31 2020	n/a	n/a	-HK$27m
Sep 30 2020	n/a	n/a	-HK$33m
Jun 30 2020	HK$2m	HK$2m	-HK$40m
Mar 31 2020	n/a	n/a	-HK$11m
Dec 31 2019	n/a	n/a	HK$19m
Sep 30 2019	n/a	n/a	HK$23m
Jun 30 2019	HK$2m	HK$2m	HK$27m
Mar 31 2019	n/a	n/a	HK$26m
Dec 31 2018	n/a	n/a	HK$25m
Sep 30 2018	n/a	n/a	HK$24m
Jun 30 2018	HK$2m	HK$2m	HK$24m

Tazminat ve Piyasa: Kin Ping 'nin toplam tazminatı ($USD 559.96K ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 233.55K ).

Tazminat ve Kazançlar: Kin Ping 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Kin Ping Chan (60 yo)

9.4yrs

Görev süresi

HK$4,358,000

Tazminat

Mr. Kin Ping Chan, BBS, J.P, serves as the Chairman of the Board at Human Health Holdings Limited and has been its Chief Executive Officer and Executive Director since June 9, 2015. Mr. Chan is a Co-Owner...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kin Ping Chan	Chairman of the Board & CEO	9.4yrs	HK$4.36m	1.8% HK$ 5.3m
Chun Pong Poon	COO & Executive Director	11.2yrs	HK$3.96m	0.13% HK$ 379.1k
Lai Sheung Pang	Chief Medical Officer & Executive Director	no data	HK$4.36m	Veri yok
Tin Wai Chan	Group CFO	1.8yrs	Veri yok	Veri yok
Siu Keung Seto	Co-Head of Dental Unit	9.3yrs	Veri yok	Veri yok
Wai Man Lau	Co-Head of Dental Unit	9.3yrs	Veri yok	Veri yok
Ching Yan Man	Company Secretary	7.4yrs	Veri yok	Veri yok

9.3yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim: 1419 'un yönetim ekibi deneyimli ve deneyimlidir ( 9.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kin Ping Chan	Chairman of the Board & CEO	9.4yrs	HK$4.36m	1.8% HK$ 5.3m
Chun Pong Poon	COO & Executive Director	9.4yrs	HK$3.96m	0.13% HK$ 379.1k
Lai Sheung Pang	Chief Medical Officer & Executive Director	9.4yrs	HK$4.36m	Veri yok
Yue Kwong Chan	Independent Non-Executive Director	8.8yrs	HK$180.00k	Veri yok
Sun Wing Lui	Independent Non-Executive Director	8.8yrs	HK$180.00k	Veri yok
Kar Tim Sin	Independent Non-Executive Director	8.8yrs	HK$180.00k	Veri yok
Kin Hung Kwong	Member of Doctor Advisory Board	15.3yrs	Veri yok	Veri yok
Huen Lee	Member of Doctor Advisory Board	12.1yrs	Veri yok	Veri yok
Hey Man Chan	Independent Non-Executive Director	less than a year	Veri yok	Veri yok

9.4yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1419 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.4 yıldır).

Human Health Holdings Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Recent updates

We Think Human Health Holdings Limited's (HKG:1419) CEO Compensation Package Needs To Be Put Under A Microscope

Full year 2024 earnings released: EPS: HK$0.064 (vs HK$0.48 in FY 2023)

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş